Exhibit 99.2
Supplemental Financial Information
First Quarter 2010
Table of Contents | PRIMERICA, INC. | |
Financial Supplement |
Page | ||
Preface, definition of Non-GAAP financial measures |
3 | |
Balance sheets |
4-5 | |
Financial results and other statistical data |
6 | |
Statements of income |
7 | |
Reconciliation of GAAP to Non-GAAP financial measures |
8-10 | |
Segment operating results |
11 | |
Term life insurance segment - financial results and key statistics |
12-13 | |
Investment and savings product segment - financial results and key statistics |
14 | |
Investment portfolio |
15-18 | |
Five-year historical key statistics |
19 |
2 of 19
Preface | PRIMERICA, INC. | |
Financial Supplement |
FIRST QUARTER 2010
This document is a financial supplement to our first quarter 2010 earnings release. It is designed to enable comprehensive analysis of our ongoing business using the same core metrics that our management utilizes in assessing our business and making strategic and operational decisions related to the business. Throughout this document we provide financial information that is derived from our U.S. GAAP financial statements and adjusted for three different purposes, as follows:
| Pro forma adjustments enable presentation of our combined balance sheets and of our combined statements of income as if the reinsurance agreements and the reorganization activities executed in March and April 2010 (as described below) had occurred at the end of the respective reporting period for the balance sheet and at the beginning of the calendar year reflected for the statement of income. Certain pro forma adjustments for transactions occurring after March 31, 2009 are estimations and are subject to change. |
| Operating adjustments exclude the impact of realized investment gains and losses, initial equity award grants awarded at the initial public offering (IPO) and accelerated vesting of existing equity awards in April 2010. |
| Adjusted when used in describing stockholders equity refers to the removal of the impact of net unrealized gains and losses on invested assets. |
Management utilizes certain non-GAAP financial measures in managing the business and believes they present relevant and meaningful analytical metrics for evaluating the ongoing business. Reconciliations of GAAP to Non-GAAP financial measures are included throughout this financial supplement.
Pro forma shares throughout this supplement assumes 75 million shares outstanding, which reflects approximately 70 million shares of common stock and approximately 5 million share-based awards granted to our management and sales force leaders in connection with the IPO. This number does not reflect the actual number of shares of common stock outstanding subsequent to March 31, 2010.
The following transactions were executed in conjunction with the IPO in March and April 2010 (the IPO-related Transactions) and are included in our actual and/or pro forma financial results as appropriate.
IPO-related Transactions executed in first quarter 2010:
| On March 31, 2010, we reinsured between 80% and 90% of our business that was in-force at year-end 2009 to various affiliates of Citigroup Inc. (Citi) and declared extraordinary dividends to Citi. |
IPO-related Transactions executed in second quarter 2010:
| On April 1, 2010, Citi contributed the legal entities comprising our business to us. We issued approximately 75.0 million shares of common stock and warrants exercisable for approximately 4.1 million additional shares of our common stock to Citi. Additionally, we issued a $300 million note to Citi, due March 31, 2015 and bearing interest at 5.5% annually. |
| On April 1, 2010, our common stock began trading under the ticker symbol PRI on the New York Stock Exchange. |
| On April 1, 2010, Citi sold approximately 24.6 million shares of our common stock (after giving effect to the over-allotment option) to the public in the IPO. |
| On April 1, 2010, Citi contributed approximately 5.0 million shares back to us, which we granted in the form of equity awards to certain of our management and sales force leaders. Of these, approximately 200,000 shares were granted to replace unvested Citi awards. |
| On April 15, 2010, Citi sold approximately 16.4 million shares and the warrants to purchase approximately 4.1 million additional shares of our common stock to private equity funds managed by Warburg Pincus LLC (Warburg Pincus) for a purchase price of $230 million (the private equity transaction). Following the IPO and the private equity transaction, certain historical Citi equity awards immediately vested, resulting in approximately $2.2 million of compensation expense and a reclassification of approximately $1.8 million from due to affiliates to paid-in capital. |
| Effective as of April 1, 2010, in connection with the IPO and the private equity transaction, elections under Section 338(h)(10) of the Internal Revenue Code will be made, which will result in changes to our deferred tax balances and reduced stockholders equity. |
The first quarter 2010 combined statement of income includes income attributable to the underlying policies that were reinsured to Citi on March 31, 2010 as well as income earned on the invested assets backing the reinsurance balances and extraordinary dividends declared as of that date. The combined balance sheet as of March 31, 2010 reflects the impact of the Citi reinsurance transactions executed on that date. As the Citi reinsurance transactions were given retroactive effect to January 1, 2010, the first quarter 2010 combined balance sheet also reflects a return of capital to Citi equally offsetting the income attributable to the underlying policies earned between January 1, 2010 and March 31, 2010. The first quarter 2010 combined balance sheet also reflects the extraordinary dividends declared on March 31, 2010.
Certain items throughout this supplement may not add due to rounding. Certain items throughout this supplement are noted as na to indicate not applicable; certain variances are noted as nm to indicate not meaningful.
3 of 19
Quarterly Balance Sheets | PRIMERICA, INC. | |
Financial Supplement |
(Dollars in thousands) |
Mar 31, 2009 |
Jun 30, 2009 |
Sep 30, 2009 |
Dec 31, 2009 |
Mar 31, 2010 |
|||||||||||||||
Combined / Consolidated Balance Sheet |
||||||||||||||||||||
Assets: |
||||||||||||||||||||
Investments and cash |
$ | 5,866,133 | $ | 6,360,019 | $ | 6,888,696 | $ | 7,096,708 | $ | 3,002,900 | ||||||||||
Due from reinsurers |
833,696 | 837,726 | 849,665 | 867,242 | 3,595,239 | |||||||||||||||
Deferred policy acquisition costs |
2,718,724 | 2,757,143 | 2,797,269 | 2,789,905 | 702,429 | |||||||||||||||
Income taxes |
| | | | 56,114 | |||||||||||||||
Other assets |
409,095 | 406,318 | 402,836 | 380,584 | 394,542 | |||||||||||||||
Separate account assets |
1,536,367 | 1,766,928 | 2,033,119 | 2,093,342 | 2,222,267 | |||||||||||||||
Total assets |
$ | 11,364,015 | $ | 12,128,134 | $ | 12,971,585 | $ | 13,227,781 | $ | 9,973,491 | ||||||||||
Liabilities: |
|
|||||||||||||||||||
Future policy benefits |
$ | 4,038,781 | $ | 4,100,628 | $ | 4,161,925 | $ | 4,197,454 | $ | 4,248,277 | ||||||||||
Other policy liabilities |
570,327 | 574,991 | 597,617 | 604,343 | 630,294 | |||||||||||||||
Income taxes |
647,037 | 740,985 | 873,367 | 890,617 | | |||||||||||||||
Other liabilities |
335,639 | 358,927 | 374,251 | 498,252 | 1,125,954 | |||||||||||||||
Separate account liabilities |
1,536,367 | 1,766,928 | 2,033,119 | 2,093,342 | 2,222,267 | |||||||||||||||
Total liabilities |
7,128,151 | 7,542,459 | 8,040,279 | 8,284,008 | 8,226,792 | |||||||||||||||
Stockholders equity: |
||||||||||||||||||||
Common stock |
| | | | | |||||||||||||||
Paid-in capital |
1,086,861 | 1,095,756 | 1,097,843 | 1,124,096 | 1,312,072 | |||||||||||||||
Retained earnings |
3,447,196 | 3,565,166 | 3,683,697 | 3,648,801 | 300,531 | |||||||||||||||
Treasury stock |
| | | | | |||||||||||||||
Accumulated other comprehensive income (loss), net: |
||||||||||||||||||||
Net unrealized investment gains (losses) not other-than-temporarily impaired |
(268,721 | ) | (67,583 | ) | 134,720 | 146,105 | 85,265 | |||||||||||||
Net unrealized investment losses other-than-temporarily impaired |
(17,174 | ) | (16,521 | ) | (17,966 | ) | (16,120 | ) | (4,245 | ) | ||||||||||
Cumulative translation adjustment |
(12,298 | ) | 8,857 | 33,012 | 40,891 | 53,076 | ||||||||||||||
Total stockholders equity |
4,235,864 | 4,585,675 | 4,931,306 | 4,943,773 | 1,746,699 | |||||||||||||||
Total liabilities and stockholders equity |
$ | 11,364,015 | $ | 12,128,134 | $ | 12,971,585 | $ | 13,227,781 | $ | 9,973,491 | ||||||||||
Reconciliation of Total Stockholders Equity to Adjusted Stockholders Equity |
||||||||||||||||||||
Total stockholders equity |
$ | 4,235,864 | $ | 4,585,675 | $ | 4,931,306 | $ | 4,943,773 | $ | 1,746,699 | ||||||||||
Reconciling items: |
||||||||||||||||||||
Net unrealized investment gains (losses) not other-than-temporarily impaired |
268,721 | 67,583 | (134,720 | ) | (146,105 | ) | (85,265 | ) | ||||||||||||
Net unrealized investment losses other-than-temporarily impaired |
17,174 | 16,521 | 17,966 | 16,120 | 4,245 | |||||||||||||||
Total reconciling items |
285,895 | 84,104 | (116,754 | ) | (129,985 | ) | (81,020 | ) | ||||||||||||
Adjusted stockholders equity |
$ | 4,521,759 | $ | 4,669,779 | $ | 4,814,552 | $ | 4,813,788 | $ | 1,665,679 | ||||||||||
Deferred Policy Acquisition Costs Rollforward |
||||||||||||||||||||
Balance, beginning of period |
$ | 2,727,422 | $ | 2,718,724 | $ | 2,757,143 | $ | 2,797,269 | $ | 2,789,905 | ||||||||||
General expenses deferred |
13,416 | 14,563 | 21,006 | 15,552 | 16,095 | |||||||||||||||
Commission costs deferred |
79,506 | 87,314 | 83,228 | 76,496 | 77,208 | |||||||||||||||
Amortization of deferred policy acquisition costs |
(94,814 | ) | (86,234 | ) | (88,736 | ) | (111,506 | ) | (91,756 | ) | ||||||||||
Transferred to reinsurers |
| | | | (2,099,941 | ) | ||||||||||||||
Foreign currency impact and other, net |
(6,806 | ) | 22,777 | 24,629 | 12,094 | 10,918 | ||||||||||||||
Balance, end of period |
$ | 2,718,724 | $ | 2,757,143 | $ | 2,797,269 | $ | 2,789,905 | $ | 702,429 | ||||||||||
Note: | The combined balance sheet as of March 31, 2010 reflects the impact of the Citi reinsurance transactions executed on March 31, 2010. The Citi reinsurance transactions were given retroactive effect to January 1, 2010. As a result, the first quarter 2010 combined balance sheet reflects a return of capital to Citi equally offsetting the income attributable to the underlying policies earned between January 1, 2010 and March 31, 2010. The first quarter 2010 combined balance sheet also reflects the extraordinary dividends declared on March 31, 2010. |
4 of 19
Actual and Pro Forma Balance Sheets | PRIMERICA, INC. | |
Financial Supplement |
December 31, 2009 | March 31, 2010 | |||||||||||||||||||||||||||
(Dollars in thousands) |
Actual | Adjustments for Reinsurance Transactions |
Other Adjustments |
(1) Pro Forma |
Actual | Other Adjustments |
(1)(2) Pro Forma |
|||||||||||||||||||||
Combined / Consolidated Balance Sheet |
||||||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||
Investments and cash |
$ | 7,096,708 | $ | (4,140,344 | ) | $ | (626,639 | ) | $ | 2,329,725 | $ | 3,002,900 | $ | (685,595 | ) | $ | 2,317,305 | |||||||||||
Due from reinsurers |
867,242 | 2,655,469 | | 3,522,711 | 3,595,239 | | 3,595,239 | |||||||||||||||||||||
Deferred policy acquisition costs |
2,789,905 | (2,122,533 | ) | | 667,372 | 702,429 | | 702,429 | ||||||||||||||||||||
Income taxes |
| 33,416 | (33,416 | ) | | 56,114 | (56,114 | ) | | |||||||||||||||||||
Other assets |
380,584 | 9,233 | (5,604 | ) | 384,213 | 394,542 | (299 | ) | 394,243 | |||||||||||||||||||
Separate account assets |
2,093,342 | | | 2,093,342 | 2,222,267 | | 2,222,267 | |||||||||||||||||||||
Total assets |
$ | 13,227,781 | $ | (3,564,759 | ) | $ | (665,659 | ) | $ | 8,997,363 | $ | 9,973,491 | $ | (742,008 | ) | $ | 9,231,483 | |||||||||||
Liabilities: |
||||||||||||||||||||||||||||
Future policy benefits |
$ | 4,197,454 | $ | | $ | | $ | 4,197,454 | $ | 4,248,277 | $ | | $ | 4,248,277 | ||||||||||||||
Other policy liabilities |
604,343 | | | 604,343 | 630,294 | | 630,294 | |||||||||||||||||||||
Income taxes |
890,617 | (799,727 | ) | 45,312 | 136,202 | | 129,886 | 129,886 | ||||||||||||||||||||
Other liabilities |
498,252 | (8,070 | ) | (10,454 | ) | 479,728 | 1,125,954 | (686,118 | ) | 439,836 | ||||||||||||||||||
Note payable |
| | 300,000 | 300,000 | | 300,000 | 300,000 | |||||||||||||||||||||
Separate account liabilities |
2,093,342 | | | 2,093,342 | 2,222,267 | | 2,222,267 | |||||||||||||||||||||
Total liabilities |
8,284,008 | (807,797 | ) | 334,858 | 7,811,069 | 8,226,792 | (256,232 | ) | 7,970,560 | |||||||||||||||||||
Stockholders equity: |
||||||||||||||||||||||||||||
Common stock |
| | 750 | 750 | | 750 | 750 | |||||||||||||||||||||
Paid-in capital |
1,124,096 | 287,013 | (430,361 | ) | 980,748 | 1,312,072 | (384,380 | ) | 927,692 | |||||||||||||||||||
Retained earnings |
3,648,801 | (2,975,308 | ) | (484,475 | ) | 189,018 | 300,531 | (30,146 | ) | 270,385 | ||||||||||||||||||
Treasury stock |
| | (72,000 | ) | (72,000 | ) | | (72,000 | ) | (72,000 | ) | |||||||||||||||||
Accumulated other comprehensive income (loss), net: |
||||||||||||||||||||||||||||
Net unrealized investment gains (losses) not other-than-temporarily impaired |
146,105 | (68,667 | ) | (14,431 | ) | 63,007 | 85,265 | | |
85,265 |
| |||||||||||||||||
Net unrealized investment losses other-than-temporarily impaired |
(16,120 | ) | | | (16,120 | ) | (4,245 | ) | | (4,245 | ) | |||||||||||||||||
Cumulative translation adjustment |
40,891 | | | 40,891 | 53,076 | | 53,076 | |||||||||||||||||||||
Total stockholders’ equity |
4,943,773 | (2,756,962 | ) | (1,000,517 | ) | 1,186,294 | 1,746,699 | (485,776 | ) | 1,260,923 | ||||||||||||||||||
Total liabilities and stockholders’ equity |
$ | 13,227,781 | $ | (3,564,759 | ) | $ | (665,659 | ) | $ | 8,997,363 | $ | 9,973,491 | $ | (742,008 | ) | $ | 9,231,483 | |||||||||||
Reconciliation of Total Stockholders Equity to Pro Forma Adjusted Stockholders Equity |
||||||||||||||||||||||||||||
Total stockholders’ equity |
$ | 1,186,294 | $ | 1,260,923 | ||||||||||||||||||||||||
Reconciling items: |
||||||||||||||||||||||||||||
Net unrealized investment gains (losses) not other-than-temporarily impaired |
(63,007 | ) | (85,265 | ) | ||||||||||||||||||||||||
Net unrealized investment losses other-than-temporarily impaired |
16,120 | 4,245 | ||||||||||||||||||||||||||
Total reconciling items |
(46,887 | ) | (81,020 | ) | ||||||||||||||||||||||||
Adjusted stockholders’ equity |
$ | 1,139,407 | $ | 1,179,903 | ||||||||||||||||||||||||
(1) | Pro forma combined balance sheets as of December 31, 2009 and March 31, 2010 as if all the first and second quarter 2010 IPO-related Transactions had been executed on December 31, 2009 and March 31, 2010, respectively. |
(2) | The reinsurance transactions were executed on March 31, 2010 and are fully reflected in our corresponding actual March 31, 2010 combined balance sheet, including a return of capital to Citi equaling the earnings on the underlying policies for the three months ended March 31, 2010. The adjustments used to derive the March 31, 2010 combined pro forma balance sheet include (a) the payment of a $676 million extraordinary dividend declared in March and paid in April; (b) a $300 million note payable executed in April 2010, and its corresponding decrease to stockholders equity as a return of capital to Citi; (c) an estimated $186 million reduction of stockholders equity and deferred tax adjustment related to our Section 338(h)(10) tax election to be effective as of April 2010; (d) the impact of certain fully vested equity awards related to the IPO; (e) the impact of certain equity awards converted from past equity awards in Citi shares that had not yet fully vested; and (f) the impact of certain past equity awards that were subject to accelerated vesting upon the IPO and the private equity transaction. The actual impact of the Section 338(h)(10) tax election is expected to be between $176 million and $196 million. |
5 of 19
Financial Results and Other Statistical Data | PRIMERICA, INC. | |
Financial Supplement |
(Dollars in thousands, except per-share data) | Q1 2010 |
|||||||||||||||||||
Pro Forma Earnings per Share |
||||||||||||||||||||
Weighted-average pro forma common shares outstanding - basic & diluted |
69,978,588 | |||||||||||||||||||
Pro forma participating share-based awards |
5,021,412 | |||||||||||||||||||
Pro forma shares |
75,000,000 | |||||||||||||||||||
Pro forma net operating income |
$ | 38,154 | ||||||||||||||||||
Dividends declared |
| |||||||||||||||||||
Undistributed pro forma net operating earnings |
$ | 38,154 | ||||||||||||||||||
Undistributed pro forma net operating earnings allocated to common stockholders - basic & diluted |
$ | 35,600 | ||||||||||||||||||
Dividends declared - allocated to common stockholders |
| |||||||||||||||||||
Total pro forma net operating earnings attributable to common stockholders |
$ | 35,600 | ||||||||||||||||||
Pro forma net operating income per common share - basic |
$ | 0.51 | ||||||||||||||||||
Pro forma net operating income per common share - diluted
|
$ | 0.51 | ||||||||||||||||||
Q1 2009 |
Q2 2009 |
Q3 2009 |
Q4 2009 |
Q1 2010 |
||||||||||||||||
Annualized Return on Equity |
||||||||||||||||||||
Average stockholders’ equity |
$ | 4,173,925 | $ | 4,410,769 | $ | 4,758,491 | $ | 4,937,540 | $ | 4,979,893 | (1) | |||||||||
Average adjusted stockholders’ equity |
$ | 4,474,419 | $ | 4,595,539 | $ | 4,742,166 | $ | 4,814,171 | $ | 4,850,452 | (1) | |||||||||
Net income return on stockholders’ equity |
10.8 | % | 12.0 | % | 10.4 | % | 10.2 | % | 11.5 | % | ||||||||||
Net income return on adjusted stockholders’ equity |
10.1 | % | 11.5 | % | 10.4 | % | 10.5 | % | 11.8 | % | ||||||||||
Net operating income return on adjusted stockholders’ equity |
10.7 | % | 12.0 | % | 11.1 | % | 10.0 | % | 10.2 | % | ||||||||||
Average pro forma adjusted stockholders’ equity |
na | na | na | na | $ | 1,159,655 | ||||||||||||||
Pro forma net operating income return on pro forma adjusted stockholders’ equity |
na | na | na | na | 13.2 | % | ||||||||||||||
Capital Structure |
||||||||||||||||||||
Debt-to-capital (2) |
na | na | na | na | na | |||||||||||||||
Pro forma debt to pro forma adjusted capital (2) |
na | na | na | na | 19.2 | % | ||||||||||||||
Cash and invested assets to stockholders’ equity |
1.4 | 1.4 | 1.4 | 1.4 | 1.7 | |||||||||||||||
Cash and invested assets to adjusted stockholders’ equity |
1.3 | 1.4 | 1.4 | 1.5 | 1.8 | |||||||||||||||
Pro forma cash and invested assets to pro forma adjusted stockholders’ equity |
na | na | na | 2.0 | 2.0 | |||||||||||||||
Pro forma adjusted stockholders’ equity per pro forma share |
na | na | na | na | $ | 15.73 | ||||||||||||||
Financial Strength Ratings |
||||||||||||||||||||
Primerica Life Insurance Company: |
||||||||||||||||||||
S&P |
AA | AA | AA | AA | AA | |||||||||||||||
A.M. Best |
A+ | A+ | A+ | A+ | A+ | |||||||||||||||
Fitch |
A+ | A+ | A+ | A+ | A+ | |||||||||||||||
(Note: In April 2010, S&P lowered Primerica Life Insurance Company’s rating to AA-) |
(1) | The reinsurance agreements executed on March 31, 2010 had a material impact on period-end stockholders equity, but only impacted one day in determining first quarter 2010 average stockholders equity and average adjusted stockholders equity. |
(2) | Capital in the debt-to-capital ratio includes stockholders equity and the note payable. |
6 of 19
Statement of Income | PRIMERICA, INC. | |
Financial Supplement |
Combined / Consolidated Primerica, Inc. | |||||||||||||||||||||||||||
YOY | |||||||||||||||||||||||||||
(Dollars in thousands) |
Q1 2009 |
Q2 2009 |
Q3 2009 |
Q4 2009 |
Q1 2010 |
$ Variance |
% Variance |
||||||||||||||||||||
Statement of Income |
|||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||
Direct premiums |
$ | 516,647 | $ | 529,004 | $ | 531,713 | $ | 535,417 | $ | 537,845 | $ | 21,198 | 4 | % | |||||||||||||
Ceded premiums |
(137,609 | ) | (158,401 | ) | (154,725 | ) | (160,019 | ) | (148,119 | ) | (10,510 | ) | -8 | % | |||||||||||||
Net premiums |
379,038 | 370,603 | 376,987 | 375,399 | 389,726 | 10,688 | 3 | % | |||||||||||||||||||
Net investment income |
82,385 | 89,755 | 88,736 | 90,450 | 82,576 | 191 | nm | ||||||||||||||||||||
Commissions and fees: |
|||||||||||||||||||||||||||
Sales-based (1) |
28,203 | 29,451 | 28,672 | 32,472 | 36,363 | 8,160 | 29 | % | |||||||||||||||||||
Asset-based (2) |
27,555 | 29,718 | 33,344 | 36,964 | 38,014 | 10,459 | 38 | % | |||||||||||||||||||
Account-based (3) |
11,089 | 10,784 | 10,717 | 10,657 | 10,208 | (881 | ) | -8 | % | ||||||||||||||||||
Other commissions and fees |
12,870 | 12,737 | 11,546 | 9,208 | 7,105 | (5,764 | ) | -45 | % | ||||||||||||||||||
Realized investment (losses) gains |
(11,259 | ) | (9,003 | ) | (11,212 | ) | 9,503 | 31,057 | 42,316 | nm | |||||||||||||||||
Other, net |
12,955 | 13,542 | 12,586 | 13,948 | 11,893 | (1,062 | ) | -8 | % | ||||||||||||||||||
Total revenues |
542,837 | 547,587 | 551,376 | 578,602 | 606,942 | 64,106 | 12 | % | |||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||
Benefits and claims |
145,749 | 151,444 | 154,631 | 148,448 | 170,735 | 24,986 | 17 | % | |||||||||||||||||||
Amortization of deferred policy acquisition costs |
94,814 | 86,234 | 88,736 | 111,506 | 91,756 | (3,058 | ) | -3 | % | ||||||||||||||||||
Insurance commissions |
14,620 | 6,396 | 6,384 | 6,988 | 6,371 | (8,249 | ) | -56 | % | ||||||||||||||||||
Insurance expenses |
40,088 | 36,203 | 39,480 | 32,989 | 37,529 | (2,558 | ) | -6 | % | ||||||||||||||||||
Sales commissions: |
|||||||||||||||||||||||||||
Sales-based (1) |
21,106 | 21,555 | 20,780 | 23,470 | 26,203 | 5,097 | 24 | % | |||||||||||||||||||
Asset-based (2) |
9,430 | 9,533 | 10,883 | 12,157 | 12,715 | 3,285 | 35 | % | |||||||||||||||||||
Other sales commissions |
9,653 | 9,301 | 8,513 | 6,374 | 4,963 | (4,690 | ) | -49 | % | ||||||||||||||||||
Interest expense |
| | | | | | |||||||||||||||||||||
Other operating expenses |
32,601 | 28,587 | 34,092 | 37,698 | 36,268 | 3,667 | 11 | % | |||||||||||||||||||
Total benefits and expenses |
368,062 | 349,253 | 363,502 | 379,630 | 386,541 | 18,479 | 5 | % | |||||||||||||||||||
Income before income taxes |
174,775 | 198,334 | 187,875 | 198,972 | 220,402 | 45,626 | 26 | % | |||||||||||||||||||
Income taxes |
62,218 | 66,214 | 64,044 | 72,890 | 77,116 | 14,898 | 24 | % | |||||||||||||||||||
Net income |
$ | 112,557 | $ | 132,120 | $ | 123,831 | $ | 126,082 | $ | 143,286 | $ | 30,728 | 27 | % | |||||||||||||
Income Before Income Taxes by Segment |
|||||||||||||||||||||||||||
Term Life |
$ | 167,704 | $ | 174,295 | $ | 167,978 | $ | 158,937 | $ | 157,750 | $ | (9,954 | ) | -6 | % | ||||||||||||
Investments & Savings |
20,371 | 20,717 | 26,221 | 26,096 | 25,447 | 5,076 | 25 | % | |||||||||||||||||||
Corporate & Other Distributed Products |
(13,300 | ) | 3,321 | (6,324 | ) | 13,939 | 37,205 | 50,505 | nm | ||||||||||||||||||
Income before income taxes |
$ | 174,775 | $ | 198,334 | $ | 187,875 | $ | 198,972 | $ | 220,402 | $ | 45,626 | 26 | % | |||||||||||||
(1) | Sales-based - revenues or commission expenses relating to the sales of mutual funds and variable annuities |
(2) | Asset-based - revenues or commission expenses relating to the value of assets in client accounts for which we earn ongoing service, distribution, and other fees |
(3) | Account-based - revenues relating to the fee generating client accounts we administer |
7 of 19
Reconciliation of GAAP to Non-GAAP Financial Measures | PRIMERICA, INC. | |
Financial Supplement |
Combined / Consolidated Primerica, Inc. | ||||||||||||||||||||||||||
YOY | ||||||||||||||||||||||||||
(Dollars in thousands) |
Q1 2009 |
Q2 2009 |
Q3 2009 |
Q4 2009 |
Q1 2010 |
$ Variance |
% Variance |
|||||||||||||||||||
Reconciliation from Total Revenues to Operating Revenues |
||||||||||||||||||||||||||
Total revenues |
$ | 542,837 | $ | 547,587 | $ | 551,376 | $ | 578,602 | $ | 606,942 | $ | 64,106 | 12 | % | ||||||||||||
Operating revenues reconciling items: |
||||||||||||||||||||||||||
Realized investment losses/gains - Corporate & Other |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Total operating revenues reconciling items |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Operating revenues |
$ | 554,095 | $ | 556,589 | $ | 562,588 | $ | 569,098 | $ | 575,885 | $ | 21,790 | 4 | % | ||||||||||||
Reconciliation from Income Before Income Taxes to Operating Income Before Income Taxes |
||||||||||||||||||||||||||
Income before income taxes |
$ | 174,775 | $ | 198,334 | $ | 187,875 | $ | 198,972 | $ | 220,402 | $ | 45,626 | 26 | % | ||||||||||||
Operating income before income taxes reconciling items: |
||||||||||||||||||||||||||
Realized investment losses/gains - Corporate & Other |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Initial & accelerated management / field grant expense - Corporate & Other |
| | | | | nm | nm | |||||||||||||||||||
Total operating income before income taxes reconciling items |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Operating income before income taxes |
$ | 186,034 | $ | 207,336 | $ | 199,087 | $ | 189,468 | $ | 189,345 | $ | 3,311 | 2 | % | ||||||||||||
Reconciliation from Net Income to Net Operating Income |
||||||||||||||||||||||||||
Net income |
$ | 112,557 | $ | 132,120 | $ | 123,831 | $ | 126,082 | $ | 143,286 | $ | 30,728 | 27 | % | ||||||||||||
Net income reconciling items: |
||||||||||||||||||||||||||
Operating income before income taxes reconciling items |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Tax impact of operating income reconciling items at effective tax rate |
(4,008 | ) | (3,006 | ) | (3,822 | ) | 3,481 | 10,866 | nm | nm | ||||||||||||||||
Total net income reconciling items |
7,251 | 5,997 | 7,390 | (6,022 | ) | (20,191 | ) | nm | nm | |||||||||||||||||
Net operating income |
$ | 119,808 | $ | 138,117 | $ | 131,221 | $ | 120,060 | $ | 123,095 | $ | 3,287 | 3 | % | ||||||||||||
8 of 19
Reconciliation of GAAP to Pro Forma Non-GAAP Financial Measures | PRIMERICA, INC. | |
Financial Supplement |
Combined / Consolidated Primerica, Inc. | ||||||||||||||||||||||||||
YOY | ||||||||||||||||||||||||||
(Dollars in thousands) |
Q1 2009 |
Q2 2009 |
Q3 2009 |
Q4 2009 |
Q1 2010 |
$ Variance |
% Variance |
|||||||||||||||||||
Reconciliation from Total Revenues to Pro Forma Operating Revenues |
||||||||||||||||||||||||||
Total revenues |
$ | 542,837 | $ | 547,587 | $ | 551,376 | $ | 578,602 | $ | 606,942 | $ | 64,106 | 12 | % | ||||||||||||
Pro forma revenues reconciling items: |
||||||||||||||||||||||||||
Ceded premiums - ceded to Citi reinsurers |
(287,755 | ) | (270,259 | ) | (266,990 | ) | (259,032 | ) | (296,328 | ) | nm | nm | ||||||||||||||
Pro rata net investment income - invested assets transferred to Citi reinsurers |
(54,607 | ) | (59,547 | ) | (58,864 | ) | (59,963 | ) | (54,735 | ) | nm | nm | ||||||||||||||
Total pro forma revenues reconciling items |
(342,361 | ) | (329,806 | ) | (325,854 | ) | (318,995 | ) | (351,064 | ) | nm | nm | ||||||||||||||
Pro forma revenues |
200,476 | 217,781 | 225,522 | 259,607 | 255,879 | 55,403 | 28 | % | ||||||||||||||||||
Pro forma operating revenue reconciling items: |
||||||||||||||||||||||||||
Realized investment losses/gains - Corporate & Other |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Total pro forma operating revenue reconciling items |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Pro forma operating revenues |
$ | 211,734 | $ | 226,783 | $ | 236,734 | $ | 250,103 | $ | 224,822 | $ | 13,087 | 6 | % | ||||||||||||
Reconciliation from Income Before Income Taxes to Pro Forma Operating Income Before Income Taxes |
||||||||||||||||||||||||||
Income before income taxes |
$ | 174,775 | $ | 198,334 | $ | 187,875 | $ | 198,972 | $ | 220,402 | $ | 45,626 | 26 | % | ||||||||||||
Pro forma income before income taxes reconciling items: |
||||||||||||||||||||||||||
Ceded premiums - ceded to Citi reinsurers |
(287,755 | ) | (270,259 | ) | (266,990 | ) | (259,032 | ) | (296,328 | ) | nm | nm | ||||||||||||||
Pro rata net investment income - invested assets transferred to Citi reinsurers |
(54,607 | ) | (59,547 | ) | (58,864 | ) | (59,963 | ) | (54,735 | ) | nm | nm | ||||||||||||||
Benefits and claims - ceded to Citi reinsurers |
109,112 | 108,383 | 107,166 | 99,325 | 128,204 | nm | nm | |||||||||||||||||||
Amortization of DAC - ceded to Citi reinsurers |
73,073 | 63,860 | 63,631 | 79,167 | 71,389 | nm | nm | |||||||||||||||||||
Insurance commissions - expense allowance received from Citi reinsurers |
1,180 | 1,409 | 1,450 | 1,484 | 1,669 | nm | nm | |||||||||||||||||||
Insurance expenses - expense allowance received from Citi reinsurers |
24,864 | 23,862 | 23,756 | 24,133 | 26,083 | nm | nm | |||||||||||||||||||
Interest expense - finance charge payable to Citi reinsurer |
(2,597 | ) | (2,700 | ) | (2,532 | ) | (3,164 | ) | (2,812 | ) | nm | nm | ||||||||||||||
Interest expense - note payable |
(4,125 | ) | (4,125 | ) | (4,125 | ) | (4,125 | ) | (4,125 | ) | nm | nm | ||||||||||||||
Other operating expenses - initial & accelerated mgmt equity grant expense |
(33,288 | ) | (3,142 | ) | (3,142 | ) | (3,142 | ) | (33,288 | ) | nm | nm | ||||||||||||||
Total pro forma income before income taxes reconciling items |
(174,143 | ) | (142,260 | ) | (139,650 | ) | (125,317 | ) | (163,944 | ) | nm | nm | ||||||||||||||
Pro forma income before income taxes |
633 | 56,074 | 48,225 | 73,654 | 56,457 | 55,825 | nm | |||||||||||||||||||
Pro forma operating income before income taxes reconciling items: |
||||||||||||||||||||||||||
Realized investment losses/gains - Corporate & Other |
11,259 | 9,003 | 11,212 | (9,503 | ) | (31,057 | ) | nm | nm | |||||||||||||||||
Initial & accelerated management / field grant expense - Corporate & Other |
33,288 | 3,142 | 3,142 | 3,142 | 33,288 | nm | nm | |||||||||||||||||||
Total pro forma operating income before income taxes reconciling items |
44,547 | 12,145 | 14,354 | (6,361 | ) | 2,231 | nm | nm | ||||||||||||||||||
Pro forma operating income before income taxes |
$ | 45,179 | $ | 68,219 | $ | 62,579 | $ | 67,293 | $ | 58,689 | $ | 13,509 | 30 | % | ||||||||||||
Reconciliation from Net Income to Pro Forma Net Operating Income |
||||||||||||||||||||||||||
Net income |
$ | 112,557 | $ | 132,120 | $ | 123,831 | $ | 126,082 | $ | 143,286 | $ | 30,728 | 27 | % | ||||||||||||
Pro forma net income reconciling items: |
||||||||||||||||||||||||||
Total pro forma income before income taxes reconciling items |
(174,143 | ) | (142,260 | ) | (139,650 | ) | (125,317 | ) | (163,944 | ) | nm | nm | ||||||||||||||
Tax impact of pro forma income reconciling items at effective tax rate |
61,993 | 47,494 | 47,605 | 45,908 | 57,362 | nm | nm | |||||||||||||||||||
Total pro forma net income reconciling items |
(112,150 | ) | (94,766 | ) | (92,046 | ) | (79,409 | ) | (106,582 | ) | nm | nm | ||||||||||||||
Pro forma net income |
407 | 37,353 | 31,786 | 46,672 | 36,703 | 36,296 | nm | |||||||||||||||||||
Pro forma net operating income reconciling items: |
||||||||||||||||||||||||||
Total pro forma operating income before income taxes reconciling items |
44,547 | 12,145 | 14,354 | (6,361 | ) | 2,231 | nm | nm | ||||||||||||||||||
Tax impact of operating income reconciling items at effective tax rate |
(15,858 | ) | (4,055 | ) | (4,893 | ) | 2,330 | (781 | ) | nm | nm | |||||||||||||||
Total pro forma net operating income reconciling items |
28,689 | 8,090 | 9,461 | (4,031 | ) | 1,451 | nm | nm | ||||||||||||||||||
Pro forma net operating income |
$ | 29,096 | $ | 45,444 | $ | 41,247 | $ | 42,641 | $ | 38,154 | $ | 9,058 | 31 | % | ||||||||||||
9 of 19
Reconciliation of GAAP to Pro Forma Non-GAAP Financial Measures by Segment | PRIMERICA, INC. | |
Financial Supplement |
1st Quarter 2010 | |||||||||||||||||||||||
(Dollars in thousands) |
(1) New Term Life Insurance |
(2) Legacy Term Life Insurance |
Term Life Insurance |
Investments & Savings Products |
Corp. & Other Distributed Products |
Total | |||||||||||||||||
Income Before Income Taxes |
|||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||
Direct premiums |
$ | 10,138 | $ | 507,794 | $ | 517,932 | $ | | $ | 19,913 | $ | 537,845 | |||||||||||
Ceded premiums |
(3,737 | ) | (140,634 | ) | (144,370 | ) | | (3,748 | ) | (148,119 | ) | ||||||||||||
Net premiums |
6,401 | 367,160 | 373,561 | | 16,165 | 389,726 | |||||||||||||||||
Net investment income |
109 | 62,109 | 62,218 | | 20,358 | 82,576 | |||||||||||||||||
Commissions and fees |
| | | 84,585 | 7,105 | 91,690 | |||||||||||||||||
Realized investment gains |
| | | | 31,057 | 31,057 | |||||||||||||||||
Other, net |
8,802 | (20 | ) | 8,782 | 2,108 | 1,004 | 11,893 | ||||||||||||||||
Total revenues |
15,312 | 429,249 | 444,561 | 86,693 | 75,689 | 606,942 | |||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||
Benefits and claims |
1,517 | 159,592 | 161,109 | | 9,626 | 170,735 | |||||||||||||||||
Amortization of deferred policy acquisition costs |
968 | 87,839 | 88,807 | 2,549 | 400 | 91,756 | |||||||||||||||||
Insurance commissions |
| 2,124 | 2,124 | 1,809 | 2,438 | 6,371 | |||||||||||||||||
Insurance expenses |
15,853 | 18,917 | 34,770 | | 2,759 | 37,529 | |||||||||||||||||
Sales commissions |
| | | 38,918 | 4,963 | 43,881 | |||||||||||||||||
Interest expense |
| | | | | | |||||||||||||||||
Other operating expenses |
| | | 17,970 | 18,298 | 36,268 | |||||||||||||||||
Total benefits and expenses |
18,338 | 268,472 | 286,810 | 61,246 | 38,484 | 386,541 | |||||||||||||||||
Income before income taxes |
$ | (3,027 | ) | $ | 160,777 | $ | 157,750 | $ | 25,447 | $ | 37,205 | $ | 220,402 | ||||||||||
Reconciliation from Total Revenues to Pro Forma Operating Revenues |
|||||||||||||||||||||||
Total revenues |
$ | 15,312 | $ | 429,249 | $ | 444,561 | $ | 86,693 | $ | 75,689 | $ | 606,942 | |||||||||||
Pro forma revenues reconciling items: |
|||||||||||||||||||||||
Ceded premiums - ceded to Citi reinsurers |
| (296,328 | ) | (296,328 | ) | | | (296,328 | ) | ||||||||||||||
Pro rata net investment income - invested assets transferred to Citi reinsurers |
| (48,609 | ) | (48,609 | ) | | (6,126 | ) | (54,735 | ) | |||||||||||||
Total pro forma revenues reconciling items |
| (344,937 | ) | (344,937 | ) | | (6,126 | ) | (351,064 | ) | |||||||||||||
Pro forma revenues |
15,312 | 84,311 | 99,623 | 86,693 | 69,563 | 255,879 | |||||||||||||||||
Pro forma operating revenue reconciling items: |
|||||||||||||||||||||||
Realized investment losses/gains |
| | | | (31,057 | ) | (31,057 | ) | |||||||||||||||
Total pro forma operating revenue reconciling items |
| | | | (31,057 | ) | (31,057 | ) | |||||||||||||||
Pro forma operating revenues |
$ | 15,312 | $ | 84,311 | $ | 99,623 | $ | 86,693 | $ | 38,506 | $ | 224,822 | |||||||||||
Reconciliation from Income Before Income Taxes to Pro Forma Operating Income Before Income Taxes |
|||||||||||||||||||||||
Income before income taxes |
$ | (3,027 | ) | $ | 160,777 | $ | 157,750 | $ | 25,447 | $ | 37,205 | $ | 220,402 | ||||||||||
Pro forma income before income taxes reconciling items: |
|||||||||||||||||||||||
Ceded premiums - ceded to Citi reinsurers |
| (296,328 | ) | (296,328 | ) | | | (296,328 | ) | ||||||||||||||
Pro rata net investment income - invested assets transferred to Citi reinsurers |
| (48,609 | ) | (48,609 | ) | | (6,126 | ) | (54,735 | ) | |||||||||||||
Benefits and claims - ceded to Citi reinsurers |
| 128,204 | 128,204 | | | 128,204 | |||||||||||||||||
Amortization of DAC - ceded to Citi reinsurers |
| 71,389 | 71,389 | | | 71,389 | |||||||||||||||||
Insurance commissions - expense allowance received from Citi reinsurers |
| 1,669 | 1,669 | | | 1,669 | |||||||||||||||||
Insurance expenses - expense allowance received from Citi reinsurers |
| 26,083 | 26,083 | | | 26,083 | |||||||||||||||||
Interest expense - finance charge payable to Citi reinsurer |
| (2,812 | ) | (2,812 | ) | | | (2,812 | ) | ||||||||||||||
Interest expense - note payable |
| | | | (4,125 | ) | (4,125 | ) | |||||||||||||||
Other operating expenses - initial & accelerated mgmt equity grant expense |
| | | | (33,288 | ) | (33,288 | ) | |||||||||||||||
Total pro forma income before income taxes reconciling items |
| (120,405 | ) | (120,405 | ) | | (43,540 | ) | (163,944 | ) | |||||||||||||
Pro forma income before income taxes |
(3,027 | ) | 40,372 | 37,346 | 25,447 | (6,335 | ) | 56,457 | |||||||||||||||
Pro forma operating income before income taxes reconciling items: |
|||||||||||||||||||||||
Realized investment losses/gains |
| | | | (31,057 | ) | (31,057 | ) | |||||||||||||||
Initial & accelerated management/field grant expense |
| | | | 33,288 | 33,288 | |||||||||||||||||
Total pro forma operating income before income taxes reconciling items |
| | | | 2,231 | 2,231 | |||||||||||||||||
Pro forma operating income before income taxes |
$ | (3,027 | ) | $ | 40,372 | $ | 37,346 | $ | 25,447 | $ | (4,104 | ) | $ | 58,689 | |||||||||
(1) | New Term Life Insurance - subsegment of the Term Life segment consisting of term life insurance policies issued after Citi reinsurance transactions |
(2) | Legacy Term Life Insurance - subsegment of the Term Life segment consisting of term life insurance policies issued before Citi reinsurance transactions |
10 of 19
Segment Operating Results | PRIMERICA, INC. | |
Financial Supplement |
Pro Forma Q1 2009 |
Pro Forma Q2 2009 |
Pro Forma Q3 2009 |
Pro Forma Q4 2009 |
Pro Forma Q1 2010 |
YOY | ||||||||||||||||||||||||||||
(Dollars in thousands) |
$ Variance |
% Variance |
|||||||||||||||||||||||||||||||
Term Life Insurance |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Direct premiums |
$ | 496,683 | $ | 507,376 | $ | 510,695 | $ | 516,234 | $ | 517,932 | $ | 21,248 | 4 | % | |||||||||||||||||||
Ceded premiums |
(422,006 | ) | (425,341 | ) | (418,216 | ) | (415,263 | ) | (440,699 | ) | (18,692 | ) | -4 | % | |||||||||||||||||||
Net premiums |
74,677 | 82,035 | 92,479 | 100,970 | 77,233 | 2,556 | 3 | % | |||||||||||||||||||||||||
Allocated net investment income |
17,832 | 19,393 | 19,178 | 19,591 | 13,609 | (4,223 | ) | -24 | % | ||||||||||||||||||||||||
Other, net |
8,615 | 7,611 | 8,939 | 8,490 | 8,782 | 167 | 2 | % | |||||||||||||||||||||||||
Operating revenues |
101,124 | 109,039 | 120,596 | 129,051 | 99,623 | (1,501 | ) | -1 | % | ||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Benefits and claims |
26,614 | 31,437 | 37,032 | 39,968 | 32,905 | 6,291 | 24 | % | |||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
19,439 | 20,506 | 23,003 | 28,984 | 17,418 | (2,020 | ) | -10 | % | ||||||||||||||||||||||||
Insurance commissions |
8,876 | 660 | 336 | 2,220 | 456 | (8,420 | ) | -95 | % | ||||||||||||||||||||||||
Insurance expenses |
11,639 | 8,848 | 12,132 | 5,504 | 8,687 | (2,952 | ) | -25 | % | ||||||||||||||||||||||||
Interest expense |
2,597 | 2,700 | 2,532 | 3,164 | 2,812 | 215 | 8 | % | |||||||||||||||||||||||||
Operating benefits and expenses |
69,165 | 64,150 | 75,036 | 79,840 | 62,278 | (6,888 | ) | -10 | % | ||||||||||||||||||||||||
Operating income before income taxes |
$ | 31,959 | $ | 44,889 | $ | 45,560 | $ | 49,212 | $ | 37,346 | $ | 5,387 | 17 | % | |||||||||||||||||||
Investments & Savings Products |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Commissions and fees: |
|||||||||||||||||||||||||||||||||
Sales-based |
$ | 28,203 | $ | 29,451 | $ | 28,672 | $ | 32,472 | $ | 36,363 | $ | 8,160 | 29 | % | |||||||||||||||||||
Asset-based |
27,555 | 29,718 | 33,344 | 36,964 | 38,014 | 10,459 | 38 | % | |||||||||||||||||||||||||
Account-based |
11,089 | 10,784 | 10,717 | 10,657 | 10,208 | (881 | ) | -8 | % | ||||||||||||||||||||||||
Other, net |
2,437 | 2,536 | 2,682 | 2,858 | 2,108 | (329 | ) | -14 | % | ||||||||||||||||||||||||
Operating revenues |
69,285 | 72,488 | 75,415 | 82,952 | 86,693 | 17,408 | 25 | % | |||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
1,936 | 1,508 | 1,304 | 2,506 | 2,549 | 613 | 32 | % | |||||||||||||||||||||||||
Insurance commissions |
1,737 | 1,482 | 1,766 | 1,845 | 1,809 | 72 | 4 | % | |||||||||||||||||||||||||
Sales commissions: |
|||||||||||||||||||||||||||||||||
Sales-based |
21,106 | 21,555 | 20,780 | 23,470 | 26,203 | 5,097 | 24 | % | |||||||||||||||||||||||||
Asset-based |
9,430 | 9,533 | 10,883 | 12,157 | 12,715 | 3,285 | 35 | % | |||||||||||||||||||||||||
Other operating expenses |
14,705 | 17,693 | 14,461 | 16,878 | 17,970 | 3,266 | 22 | % | |||||||||||||||||||||||||
Operating benefits and expenses |
48,914 | 51,771 | 49,194 | 56,856 | 61,246 | 12,332 | 25 | % | |||||||||||||||||||||||||
Operating income before income taxes |
$ | 20,371 | $ | 20,717 | $ | 26,221 | $ | 26,096 | $ | 25,447 | $ | 5,076 | 25 | % | |||||||||||||||||||
Corporate & Other Distributed Products |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Direct premiums |
$ | 19,964 | $ | 21,628 | $ | 21,018 | $ | 19,184 | $ | 19,913 | $ | (51 | ) | nm | |||||||||||||||||||
Ceded premiums |
(3,357 | ) | (3,319 | ) | (3,499 | ) | (3,787 | ) | (3,748 | ) | (391 | ) | -12 | % | |||||||||||||||||||
Net premiums |
16,606 | 18,309 | 17,518 | 15,396 | 16,165 | (442 | ) | -3 | % | ||||||||||||||||||||||||
Allocated net investment income |
9,946 | 10,815 | 10,695 | 10,897 | 14,232 | 4,286 | 43 | % | |||||||||||||||||||||||||
Commissions and fees: |
|||||||||||||||||||||||||||||||||
Loans |
8,832 | 8,685 | 7,401 | 4,738 | 2,455 | (6,377 | ) | -72 | % | ||||||||||||||||||||||||
DebtWatchers |
| 1 | 120 | 386 | 620 | 620 | nm | ||||||||||||||||||||||||||
Prepaid Legal Services |
2,438 | 2,338 | 2,323 | 2,316 | 2,340 | (98 | ) | -4 | % | ||||||||||||||||||||||||
Auto and Homeowners Insurance |
844 | 994 | 994 | 1,104 | 1,012 | 167 | 20 | % | |||||||||||||||||||||||||
Long-Term Care Insurance |
755 | 719 | 709 | 664 | 679 | (77 | ) | -10 | % | ||||||||||||||||||||||||
Other, net |
1,903 | 3,395 | 964 | 2,600 | 1,004 | (900 | ) | -47 | % | ||||||||||||||||||||||||
Operating revenues |
41,325 | 45,256 | 40,723 | 38,100 | 38,506 | (2,820 | ) | -7 | % | ||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Benefits and claims |
10,023 | 11,625 | 10,433 | 9,155 | 9,626 | (397 | ) | -4 | % | ||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
366 | 360 | 798 | 849 | 400 | 34 | 9 | % | |||||||||||||||||||||||||
Insurance commissions |
2,827 | 2,845 | 2,832 | 1,439 | 2,438 | (389 | ) | -14 | % | ||||||||||||||||||||||||
Insurance expenses |
3,585 | 3,493 | 3,592 | 3,352 | 2,759 | (826 | ) | -23 | % | ||||||||||||||||||||||||
Sales commissions |
9,653 | 9,301 | 8,513 | 6,374 | 4,963 | (4,690 | ) | -49 | % | ||||||||||||||||||||||||
Interest expense |
4,125 | 4,125 | 4,125 | 4,125 | 4,125 | | nm | ||||||||||||||||||||||||||
Other operating expenses |
17,896 | 10,894 | 19,631 | 20,820 | 18,298 | 401 | 2 | % | |||||||||||||||||||||||||
Operating benefits and expenses |
48,476 | 42,643 | 49,925 | 46,114 | 42,609 | (5,866 | ) | -12 | % | ||||||||||||||||||||||||
Operating income before income taxes |
$ | (7,150 | ) | $ | 2,613 | $ | (9,201 | ) | $ | (8,014 | ) | $ | (4,104 | ) | $ | 3,046 | 43 | % | |||||||||||||||
11 of 19
Term Life Insurance - Financial Results | PRIMERICA, INC. | |
Financial Supplement |
Pro
Forma Q1 2009 |
Pro
Forma Q2 2009 |
Pro
Forma Q3 2009 |
Pro
Forma Q4 2009 |
Pro
Forma Q1 2010 |
YOY | ||||||||||||||||||||||||||||
(Dollars in thousands) |
$ Variance |
% Variance |
|||||||||||||||||||||||||||||||
Term Life Insurance Operating Income Before Income Taxes |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Direct premiums |
$ | 496,683 | $ | 507,376 | $ | 510,695 | $ | 516,234 | $ | 517,932 | $ | 21,248 | 4 | % | |||||||||||||||||||
Ceded premiums |
(422,006 | ) | (425,341 | ) | (418,216 | ) | (415,263 | ) | (440,699 | ) | (18,692 | ) | -4 | % | |||||||||||||||||||
Net premiums |
74,677 | 82,035 | 92,479 | 100,970 | 77,233 | 2,556 | 3 | % | |||||||||||||||||||||||||
Net investment income |
17,832 | 19,393 | 19,178 | 19,591 | 13,609 | (4,223 | ) | -24 | % | ||||||||||||||||||||||||
Other, net |
8,615 | 7,611 | 8,939 | 8,490 | 8,782 | 167 | 2 | % | |||||||||||||||||||||||||
Operating revenues |
101,124 | 109,039 | 120,596 | 129,051 | 99,623 | (1,501 | ) | -1 | % | ||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Benefits and claims |
26,614 | 31,437 | 37,032 | 39,968 | 32,905 | 6,291 | 24 | % | |||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
19,439 | 20,506 | 23,003 | 28,984 | 17,418 | (2,020 | ) | -10 | % | ||||||||||||||||||||||||
Insurance commissions |
8,876 | 660 | 336 | 2,220 | 456 | (8,420 | ) | -95 | % | ||||||||||||||||||||||||
Insurance expenses |
11,639 | 8,848 | 12,132 | 5,504 | 8,687 | (2,952 | ) | -25 | % | ||||||||||||||||||||||||
Interest expense |
2,597 | 2,700 | 2,532 | 3,164 | 2,812 | 215 | 8 | % | |||||||||||||||||||||||||
Operating benefits and expenses |
69,165 | 64,150 | 75,036 | 79,840 | 62,278 | (6,888 | ) | -10 | % | ||||||||||||||||||||||||
Operating income before income taxes |
$ | 31,959 | $ | 44,889 | $ | 45,560 | $ | 49,212 | $ | 37,346 | $ | 5,387 | 17 | % | |||||||||||||||||||
New Term Life Insurance Operating Income Before Income Taxes |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Direct premiums |
na | na | na | na | $ | 10,138 | |||||||||||||||||||||||||||
Ceded premiums |
na | na | na | na | (3,737 | ) | |||||||||||||||||||||||||||
Net premiums |
na | na | na | na | 6,401 | ||||||||||||||||||||||||||||
Net investment income |
na | na | na | na | 109 | ||||||||||||||||||||||||||||
Other, net |
na | na | na | na | 8,802 | ||||||||||||||||||||||||||||
Operating revenues |
na | na | na | na | 15,312 | ||||||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Benefits and claims |
na | na | na | na | 1,517 | ||||||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
na | na | na | na | 968 | ||||||||||||||||||||||||||||
Insurance commissions |
na | na | na | na | | ||||||||||||||||||||||||||||
Insurance expenses |
na | na | na | na | 15,853 | ||||||||||||||||||||||||||||
Interest expense |
na | na | na | na | | ||||||||||||||||||||||||||||
Operating benefits and expenses |
na | na | na | na | 18,338 | ||||||||||||||||||||||||||||
Operating income before income taxes |
na | na | na | na | $ | (3,027 | ) | ||||||||||||||||||||||||||
Legacy Term Life Insurance Operating Income Before Income Taxes |
|||||||||||||||||||||||||||||||||
Revenues: |
|||||||||||||||||||||||||||||||||
Direct premiums |
na | na | na | na | $ | 507,794 | |||||||||||||||||||||||||||
Ceded premiums |
na | na | na | na | (436,962 | ) | |||||||||||||||||||||||||||
Net premiums |
na | na | na | na | 70,832 | ||||||||||||||||||||||||||||
Net investment income |
na | na | na | na | 13,500 | ||||||||||||||||||||||||||||
Other, net |
na | na | na | na | (20 | ) | |||||||||||||||||||||||||||
Operating revenues |
na | na | na | na | 84,311 | ||||||||||||||||||||||||||||
Benefits and expenses: |
|||||||||||||||||||||||||||||||||
Benefits and claims |
na | na | na | na | 31,388 | ||||||||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
na | na | na | na | 16,450 | ||||||||||||||||||||||||||||
Insurance commissions |
na | na | na | na | 456 | ||||||||||||||||||||||||||||
Insurance expenses |
na | na | na | na | (7,166 | ) | |||||||||||||||||||||||||||
Interest expense |
na | na | na | na | 2,812 | ||||||||||||||||||||||||||||
Operating benefits and expenses |
na | na | na | na | 43,939 | ||||||||||||||||||||||||||||
Operating income before income taxes |
na | na | na | na | $ | 40,372 | |||||||||||||||||||||||||||
12 of 19
Term Life Insurance - Key Statistics and Financial Analysis | PRIMERICA, INC. | |
Financial Supplement |
Q1 2009 |
Q2 2009 |
Q3 2009 |
Q4 2009 |
Q1 2010 |
YOY | ||||||||||||||||||||||||||
(Dollars in thousands, except as noted) |
$ Variance |
% Variance |
|||||||||||||||||||||||||||||
Key Statistics |
|||||||||||||||||||||||||||||||
Life-insurance licensed sales force (end of period) |
100,409 | 100,672 | 101,095 | 99,785 | 97,354 | (3,055 | ) | -3 | % | ||||||||||||||||||||||
Estimated annualized issued term life premium ($mills) (1) |
$ | 54 | $ | 62 | $ | 59 | $ | 61 | $ | 54 | $ | | nm | ||||||||||||||||||
Issued term life policies |
53,023 | 62,202 | 58,070 | 60,542 | 52,445 | (578 | ) | -1 | % | ||||||||||||||||||||||
Term life face amount in force, beginning of period ($mills) |
$ | 633,467 | $ | 631,566 | $ | 639,377 | $ | 646,341 | $ | 650,195 | $ | 16,729 | 3 | % | |||||||||||||||||
Issued term life face amount (2) |
18,660 | 21,070 | 19,909 | 20,858 | 17,997 | (663 | ) | -4 | % | ||||||||||||||||||||||
Terminated term life face amount |
(19,781 | ) | (16,564 | ) | (17,302 | ) | (19,474 | ) | (18,750 | ) | 1,031 | 5 | % | ||||||||||||||||||
Foreign currency impact, net |
(779 | ) | 3,304 | 4,357 | 2,471 | 2,348 | 3,127 | nm | |||||||||||||||||||||||
Term life face amount in force, end of period |
$ | 631,566 | $ | 639,377 | $ | 646,341 | $ | 650,195 | $ | 651,790 | $ | 20,223 | 3 | % | |||||||||||||||||
Pro
Forma Q1 2009 |
Pro
Forma Q2 2009 |
Pro
Forma Q3 2009 |
Pro
Forma Q4 2009 |
Pro
Forma Q1 2010 |
|||||||||||||||||||||||||||
New Term Life Insurance - Financial Analysis |
|||||||||||||||||||||||||||||||
Direct premium |
na | na | na | na | $ | 10,138 | |||||||||||||||||||||||||
New term life operating income before income taxes |
na | na | na | na | $ | (3,027 | ) | ||||||||||||||||||||||||
% of direct premium |
na | na | na | na | -29.9 | % | |||||||||||||||||||||||||
Benefits & expenses, net (3) |
na | na | na | na | $ | 6,222 | |||||||||||||||||||||||||
% of direct premium |
na | na | na | na | 61.4 | % | |||||||||||||||||||||||||
Insurance expenses, net (4) |
na | na | na | na | $ | 7,051 | |||||||||||||||||||||||||
% of direct premium |
na | na | na | na | 69.6 | % | |||||||||||||||||||||||||
Legacy Term Life Insurance - Financial Analysis |
|||||||||||||||||||||||||||||||
Direct premium |
na | na | na | na | $ | 507,794 | |||||||||||||||||||||||||
Legacy term life operating income before income taxes |
na | na | na | na | $ | 40,372 | |||||||||||||||||||||||||
% of direct premium |
8.0 | % |
(1) | Estimated annualized issued term life premium - estimated as average premium per $1,000 of face amounts issued on new policies and additions (before free look returns) multiplied by actual face amount issued on new policies, rider additions and face amount increases. |
(2) | Issued term life face amount - includes face amount on issued term life policies, additional riders added to existing policies, and face increases under increasing benefit riders |
(3) | Benefits & expenses, net - includes total benefits & claims, ceded premiums, insurance commissions, and amortization of deferred policy acquisition costs |
(4) | Insurance expenses, net - insurance expenses net of other net revenues |
13 of 19
Investments and Savings Product - Financial Results, Key Statistics, and Financial Analysis | PRIMERICA, INC. | |
Financial Supplement |